Similarly, Pten-mutant mice develop mPIN and prostate cancer [10]–[13] and Pten inactivation can cooperate with mutations in oncogenes and tumor suppressors in prostate tumorigenesis, including p27Kip1[14],[15], Trp53[13] and Fgf8b[16]. Here, TP53 is linked to prostate carcinoma.